JAK2-V617F–triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell …

N Kröger, H Alchalby, E Klyuchnikov… - Blood, The Journal …, 2009 - ashpublications.org
With great interest we have read the letter by Terriou and coworkers, who have performed
an extensive survey of CEBPA CpG promoter hypermethylation in T-ALL as well as in a …
被引用次数：100 相关文章

[引用][C] JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell …

N Kröger, H Alchalby, E Klyuchnikov, A Badbaran… - Blood, 2009 - europepmc.org
JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte
infusion in patients with myelofibrosis after allogeneic stem cell transplantation. - Abstract …

[引用][C] JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell …

N KROGER - Blood, 2009 - cir.nii.ac.jp
JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte
infusion in patients with myelofibrosis after allogeneic stem cell transplantation | CiNii …

[引用][C] JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell …

N Kröger, H Alchalby, E Klyuchnikov, A Badbaran… - …, 2009 - pubmed.ncbi.nlm.nih.gov
JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte
infusion in patients with myelofibrosis after allogeneic stem cell transplantation JAK2-V617F-triggered …

[引用][C] JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell …

N KRÖGER, H ALCHALBY… - …, 2009 - Americain Society of Hematology